Perrigo Co PLC (PRGO) Financials

Perrigo Co PLC (PRGO) is a global healthcare company that specializes in the production of over-the-counter (OTC) and generic prescription pharmaceuticals. The company's financials for the latest fiscal year are as follows. Starting with the income statement, Perrigo Co PLC reported a gross profit of $2.3 billion. The company's EBIT, or earnings before interest and taxes, stood at $1.1 billion. The EBITDA, or earnings before interest, taxes, depreciation, and amortization, amounted to $1.4 billion. Net income from stockholders reached $614 million. Perrigo Co PLC achieved a total revenue of $4.8 billion during the fiscal year.

Moving on to the balance sheet, Perrigo Co PLC's cash equivalents were valued at $315 million. The company's net debt stood at $3.2 billion, while the stockholders' equity amounted to $5.1 billion. In terms of total assets, Perrigo Co PLC reported $15.2 billion, with total debt reaching $8.9 billion. Lastly, the total liabilities stood at $10.1 billion. The cash flow statement revealed that Perrigo Co PLC generated $785 million in operating cash flow, $127 million in financing cash flow, and $117 million in investing cash flow. The company's free cash flow amounted to $668 million.